×
News Home

Is Moderna Inc (MRNA) Stock Worth a Buy Monday?

Monday, June 14, 2021 10:52 AM | InvestorsObserver Analysts
Is Moderna Inc (MRNA) Stock Worth a Buy Monday?

Moderna Inc (MRNA) stock has risen 203.74% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives MRNA stock a score of 82 out of a possible 100.

That rank is chiefly influenced by a short-term technical score of 96. MRNA's rank also includes a long-term technical score of 91. The fundamental score for MRNA is 59. In addition to the average rating from Wall Street analysts, MRNA stock has a mean target price of 162.545. This means analysts expect the stock to decline 19.61% over the next 12 months.

Overall Score - 82
MRNA has an Overall Score of 82. Find out what this means to you and get the rest of the rankings on MRNA!

What's Happening with MRNA Stock Today

Moderna Inc (MRNA) stock is lower by -7.61% while the S&P 500 is lower by -0.22% as of 10:42 AM on Monday, Jun 14. MRNA is lower by -$16.65 from the previous closing price of $218.85 on volume of 5,457,782 shares. Over the past year the S&P 500 is higher by 38.20% while MRNA has risen 203.74%. MRNA earned $1.25 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 161.91.

Click Here to get the full Stock Score Report on Moderna Inc (MRNA) Stock.

You May Also Like